Linical Accelovance is a market-leading, midsized, global contract research organization (CRO). Linical Accelovance offers a personalized, hands-on service approach in all phases of development across a variety of therapeutic areas including vaccines, oncology, CNS, and general medicine. With a significant footprint across North America, Europe and Asia-Pacific, Linical Accelovance is the ideal partner for drug developers looking to expand their program into new markets. Providing global full CRO services to pharmaceutical companies, biotechs, CROs, and academic institutions; Linical Accelovance supports client needs by leveraging operational knowledge and patient recruitment strategies that result in successful clinical trials.
Please Visit our website here: https://www.accelovance.com/therapeutic_expertise/vaccines